4D Molecular Therapeutics
FDMT
FDMT
110 hedge funds and large institutions have $534M invested in 4D Molecular Therapeutics in 2023 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 42 increasing their positions, 33 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
110
Holders Change
+10
Holders Change %
+10%
% of All Funds
1.75%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
20
Increased
42
Reduced
33
Closed
10
Calls
$294K
Puts
$286K
Net Calls
+$8K
Net Calls Change
+$603K
Top Buyers
| 1 |
RCM
1
RA Capital Management
Boston,
Massachusetts
|
$53M |
| 2 |
2
Dimensional Fund Advisors
Austin,
Texas
|
$8.54M |
| 3 |
3
BlackRock
New York
|
$39.8M |
| 4 |
NHAS
4
Novo Holdings A/S
Hellerup,
Denmark
|
$15.3M |
| 5 |
GC
5
GMT Capital
Atlanta,
Georgia
|
$1.92M |
